Enablex and Atacand drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Enablex (darifenacin hydrobromide) and Atacand (candesartan cilexetil). Common drug interactions include amnesia among females and decreased appetite among males.

The phase IV clinical study analyzes what interactions people have when they take Enablex and Atacand. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Enablex?

Enablex has active ingredients of darifenacin hydrobromide. It is often used in urge incontinence. eHealthMe is studying from 4,934 Enablex users. Check the latest studies of Enablex.

What is Atacand?

Atacand has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 22,473 Atacand users. Check the latest studies of Atacand.



On Jul, 26, 2026

20 people who take Enablex and Atacand together, and have interactions are studied.

Enablex and Atacand drug interactions.

What are the common drug interactions of Enablex and Atacand, by gender? *:

female:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Conjunctivitis (pink eye)
  3. Pain
  4. Pneumonia
  5. Nausea (feeling of having an urge to vomit)
  6. Oedema peripheral (superficial swelling)
  7. Vomiting
  8. Fatigue (feeling of tiredness)
  9. Urinary tract infection
  10. Weight decreased

male:

  1. Decreased appetite
  2. Depression
  3. Dyspepsia (indigestion)
  4. Hyperchlorhydria (gastric acid levels are higher in stomach)
  5. Retching (strong involuntary effort to vomit)
  6. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

What are the common drug interactions of Enablex and Atacand, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Hypoaesthesia (reduced sense of touch or sensation)
  3. Injection site haematoma (localized swelling filled with blood at injection site)
  4. Oedema peripheral (superficial swelling)
  5. Open wound
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Rash erythematous (redness of the skin)
  8. Skin atrophy (wasting of skin)

60+:

  1. Emotional disorder
  2. Fall
  3. Fatigue (feeling of tiredness)
  4. Urinary tract infection
  5. Weight decreased
  6. Cardiac failure
  7. Oedema peripheral (superficial swelling)
  8. Pulmonary hypertension (increase in blood pressure in the lung artery)
  9. Cardiac murmur (an heart sound in valve abnormality)
  10. Cardiac output decreased

What are the existing conditions these people have? *

  1. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 4 people, 20.00%
  2. Micturition Urgency (urgency to pass the urine): 2 people, 10.00%
  3. Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 5.00%
  4. Incontinence (lack of moderation or self-control): 1 person, 5.00%
  5. Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 5.00%
  6. Bipolar Disorder (mood disorder): 1 person, 5.00%
  7. Bladder Pain: 1 person, 5.00%
  8. Cluster Headache (one-sided head pain with tearing): 1 person, 5.00%
  9. Colitis (inflammation of colon): 1 person, 5.00%
  10. Constipation: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Enablex and Atacand?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Enablex and Atacand:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Enablex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Atacand:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Enablex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atacand and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on darifenacin hydrobromide and candesartan cilexetil (the active ingredients of Enablex and Atacand, respectively), and Enablex and Atacand (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: